Other Resources:
DOI: 10.1182/blood.2021014689
Paper Summary:
Title: Asciminib: new therapeutic option in chronic phase CML with treatment failure.
Author(s): Yeung, David T; Shanmuganathan, Naranie; Hughes, Timothy P
Year: 2022
DOI: 10.1182/blood.2021014689
URL: https://doi.org/10.1182/blood.2021014689
Received on: 2022-10-26
✍: FYIcenter.com
2022-10-26, 428👍, 0💬
Related Topics:
Popular Posts:
Paper Summary: Title: IMPACT OF COVID-19 ON EUROPEAN AND TURKEY AIR TRAFFIC NETWORKS Author(s): TUNC...
Paper Summary: Title: Seasonal Influenza and Low Flu Vaccination Coverage as Important Factors Modif...
How to use the PDF File Download service at ftp.ncbi.nlm.nih.gov/pub /pmc?The PDF File Download serv...
How to download research paper with PaperPanda - Chrome Extension? If you have PaperPanda installed ...
How to use the Article Package Download service at ftp.ncbi.nlm.nih.gov/pub /pmc?The Article Package...
